Department of Molecular Oncology, BC Cancer Agency, Vancouver V5Z 1L3, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver V6T 2B5, Canada.
Cold Spring Harb Perspect Med. 2018 Feb 1;8(2):a029603. doi: 10.1101/cshperspect.a029603.
The ability to accurately model evolutionary dynamics in cancer would allow for prediction of progression and response to therapy. As a prelude to quantitative understanding of evolutionary dynamics, researchers must gather observations of in vivo tumor evolution. High-throughput genome sequencing now provides the means to profile the mutational content of evolving tumor clones from patient biopsies. Together with the development of models of tumor evolution, reconstructing evolutionary histories of individual tumors generates hypotheses about the dynamics of evolution that produced the observed clones. In this review, we provide a brief overview of the concepts involved in predicting evolutionary histories, and provide a workflow based on bulk and targeted-genome sequencing. We then describe the application of this workflow to time series data obtained for transformed and progressed follicular lymphomas (FL), and contrast the observed evolutionary dynamics between these two subtypes. We next describe results from a spatial sampling study of high-grade serous (HGS) ovarian cancer, propose mechanisms of disease spread based on the observed clonal mixtures, and provide examples of diversification through subclonal acquisition of driver mutations and convergent evolution. Finally, we state implications of the techniques discussed in this review as a necessary but insufficient step on the path to predictive modelling of disease dynamics.
准确地对癌症中的进化动力学进行建模,将能够预测肿瘤的进展和对治疗的反应。作为对进化动力学进行定量理解的前奏,研究人员必须收集对体内肿瘤进化的观察结果。高通量基因组测序现在为从患者活检中分析不断进化的肿瘤克隆的突变内容提供了手段。随着肿瘤进化模型的发展,重建单个肿瘤的进化史会产生关于产生观察到的克隆的进化动态的假设。在这篇综述中,我们简要概述了预测进化史所涉及的概念,并提供了基于 bulk 和靶向基因组测序的工作流程。然后,我们描述了该工作流程在转化和进展滤泡性淋巴瘤 (FL) 的时间序列数据中的应用,并比较了这两种亚型之间观察到的进化动态。接下来,我们描述了高级别浆液性 (HGS) 卵巢癌的空间采样研究结果,根据观察到的克隆混合物提出疾病传播的机制,并提供了通过亚克隆获得驱动突变和趋同进化进行多样化的例子。最后,我们说明了本文讨论的技术的意义,作为对疾病动力学进行预测建模的必要但不充分步骤。